An eye-catching South Bay office building that was once the headquarters of bankrupt biotech company 23andMe has been bought at a price that reflects a massive decline in the property's value. The ...

Fresh from a $150 million IPO on Wall Street, Omada Health CEO Sean Duffy shares his thoughts on speed bumps, GLP-1s, staying ...

Take a fascinating look back at the science and technology advances that shaped medicine’s past and will define its future.

A long shot provision in President Donald Trump’s budget bill raises questions about whether proposed court limits would ...

I wrote about a new company called 23andMe, which would take a sample of your DNA and tell you all sorts of interesting stuff ...

The move marks a turning point in 23andMe’s tumultuous decline. Founded in 2006 by Wojcicki, the company initially gained traction with its saliva-based ancestry kits and went public in 2021. By the ...

Me is proposing to reopen its bankruptcy auction to entertain a final offer from a nonprofit operated by its co-founder, ...

After a brief court dispute, 23andMe and all its assets are up for auction once again. The second time around, former CEO Amy ...

Me wants to reopen bidding on its assets after former CEO Anne Wojcicki put together a $305 million offer, topping Regeneron.

Court filings give insight into why shooting suspect Louis Mangione might have targeted the UnitedHealthcare executive: "It checks every box." In other news: Hospital construction trends include AI; ...

Me (OTC:MEHCQ) faces a second auction after a $305M bid challenges Regeneron's (REGN) initial bid for its assets. Read more ...

Bankrupt genetic testing firm 23andMe is seeking to reopen bidding on its assets, including over 15 million customer DNA ...